Cannabis has been used for centuries to treat a variety of ailments, including chronic pain. But which of its two main components, CBD and THC, is more effective at relieving pain? A government-backed review of cannabis research found that THC might be more effective at relieving chronic pain than CBD. CBD is a promising pharmaceutical agent for treating pain, inflammation, seizures and anxiety without the psychoactive effects of THC. It works by interacting with the body's endocannabinoid system, which regulates many processes such as metabolism, appetite, mood and anxiety, and pain perception.
CBD-infused ointments are available that contain THC-free CBD extracted from hemp. In a phase II study, participants who received a combination of CBD and THC compounds saw the frequency of their migraine attacks drop by 40.4 percent. People report using CBD for anxiety, pain, sleep, all of which are associated with chronic pain. While preliminary clinical studies and animal studies suggest that CBD may help relieve pain, more research is needed to evaluate these findings.
Researchers have also found that cannabidiol may be effective in helping to relieve pain after rotator cuff surgery without serious side effects or a high risk of addiction. CBD has gained popularity as a promising complementary remedy for several health problems, such as anxiety, epilepsy, and pain control. In addition to being used as a standalone treatment for pain management, CBD can also be used in combination with other medications. For example, researchers found that compared to placebo, Sativex significantly improved participants' pain during movement, pain at rest, and quality of sleep when used to treat rheumatoid arthritis.
There are a wide range of CBD products available on the market today, including oils, tinctures, balms and candies. It is important to start with a small dose and slowly increase it until you begin to experience relief from your symptoms in a matter of weeks. However, it is important to note that the FDA has tested the chemical content of some cannabinoid compounds in products and found that many did not contain the levels of CBD that manufacturers had claimed they do.